A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants-Reference-Cited by-同舟云学术

A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants

Published:2015-04-23 Issue:7 Volume:36 Page:757-768
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:CARCIN

Author:

Sun Feng,Indran Inthrani R.,Zhang Zhi Wei,Tan M.H.Eileen,Li Yu,Lim Z.L.Ryan,Hua Rui,Yang Chong,Soon Fen-Fen,Li Jun,Xu H.Eric,Cheung Edwin,Yong Eu-Leong

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/36/7/757/5094676/bgv040.pdf

Reference43 articles.

1. Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

2. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

3. Defining a new testosterone threshold for medical castration: Results from a prospective cohort series;Dason;Can. Urol. Assoc. J,2013

4. Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

5. Molecular determinants of resistance to antiandrogen therapy

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Yishentongluo Recipe on Nrf2 and HO-1 pathway activation leading to reduction of oxidative stress and kidney fibrosis in membranous nephropathy rat model;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;2024-09-30

2. Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor;Integrative Medicine in Nephrology and Andrology;2024-07-31

3. Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer;Journal of Experimental & Clinical Cancer Research;2024-05-23

4. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives;Drug Development Research;2024-04

5. Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy – obstacles and perspectives;Transcription;2024-03-28